These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31548433)

  • 1. Identification of a novel microRNA recurrence-related signature and risk stratification system in breast cancer.
    Lai J; Chen B; Zhang G; Wang Y; Mok H; Wen L; Pan Z; Su F; Liao N
    Aging (Albany NY); 2019 Sep; 11(18):7525-7536. PubMed ID: 31548433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel six-microRNA-based model to improve prognosis prediction of breast cancer.
    Lai J; Wang H; Pan Z; Su F
    Aging (Albany NY); 2019 Jan; 11(2):649-662. PubMed ID: 30696800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.
    Yang Y; Qu A; Zhao R; Hua M; Zhang X; Dong Z; Zheng G; Pan H; Wang H; Yang X; Zhang Y
    Mol Oncol; 2018 Dec; 12(12):2072-2084. PubMed ID: 30242969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
    Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
    BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
    Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
    Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying a new microRNA signature as a prognostic biomarker in colon cancer.
    Lv Y; Duanmu J; Fu X; Li T; Jiang Q
    PLoS One; 2020; 15(2):e0228575. PubMed ID: 32049961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
    Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
    Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
    Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
    Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A three-microRNA signature predicts clinical outcome in breast cancer patients.
    Cheng D; He H; Liang B
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6386-6395. PubMed ID: 30338807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
    Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
    Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a MicroRNA-Based Nomogram for Prediction of Lung Metastasis in Breast Cancer Patients.
    Zhang L; Pan J; Wang Z; Yang C; Huang J
    Front Genet; 2020; 11():580138. PubMed ID: 33679865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients.
    Chen W; Yu Q; Chen B; Lu X; Li Q
    Oncotarget; 2016 Aug; 7(33):53392-53413. PubMed ID: 27438144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
    Yao Y; Liu R; Gao C; Zhang T; Qi L; Liu G; Zhang W; Wang X; Li J; Li J; Sun C
    J Cell Biochem; 2019 Sep; 120(9):15378-15388. PubMed ID: 31037764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of breast cancer: a potential novel immune-related lncRNAs signature.
    Lai J; Chen B; Zhang G; Li X; Mok H; Liao N
    J Transl Med; 2020 Nov; 18(1):416. PubMed ID: 33160384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer.
    Tang J; Ma W; Zeng Q; Tan J; Cao K; Luo L
    Dis Markers; 2019; 2019():3815952. PubMed ID: 31976020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
    Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
    Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Function Analysis of a Five-Long Noncoding RNA Prognostic Signature for Endometrial Cancer Patients.
    Tang H; Wu Z; Zhang Y; Xia T; Liu D; Cai J; Ye Q
    DNA Cell Biol; 2019 Dec; 38(12):1480-1498. PubMed ID: 31539276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Novel Six-miRNA-Based Model to Predict Overall Survival Among Colon Adenocarcinoma Patients.
    Rong Z; Rong Y; Li Y; Zhang L; Peng J; Zou B; Zhou N; Pan Z
    Front Oncol; 2020; 10():26. PubMed ID: 32154160
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
    Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.